GLP-1 receptor agonists as a drug class have substantial clinical trial evidence supporting significant weight loss outcomes, with peer-reviewed research demonstrating statistically meaningful reductions in body weight in large randomized controlled trials
Addiction/mental health A study of more than 2 million people with diabetes taking the popular weight-loss drugs found the medications were associated with reduced risks of seizures and addiction to substances such as alcohol, cannabis, stimulants and opioids
Reducing the Risk of Lipohypertrophy Repeated injections in the same spot can cause lipohypertrophy , a medical term for fatty lumps or thickened areas that form just under your skin
however, pica (consumption of nonnutritive materials), a rodent correlate of nausea 47 , was more frequently observed with exendin-4 administration (Fig
Our providers will create a personalized dosing schedule and help you understand the importance of rotating injection sites to prevent skin irritation or lipodystrophy
Mann JFE, Hansen T, Idorn T, et al